Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Alzheimer's disease in Down syndrome: An overlooked population for prevention trials.

Strydom A, Coppus A, Blesa R, Danek A, Fortea J, Hardy J, Levin J, Nuebling G, Rebillat AS, Ritchie C, van Duijn C, Zaman S, Zetterberg H.

Alzheimers Dement (N Y). 2018 Dec 13;4:703-713. doi: 10.1016/j.trci.2018.10.006. eCollection 2018. Review.

2.

Gait analysis in PSP and NPH: Dual-task conditions make the difference.

Selge C, Schoeberl F, Zwergal A, Nuebling G, Brandt T, Dieterich M, Schniepp R, Jahn K.

Neurology. 2018 Mar 20;90(12):e1021-e1028. doi: 10.1212/WNL.0000000000005168. Epub 2018 Feb 21.

PMID:
29467306
3.

PROSPERA: a randomized, controlled trial evaluating rasagiline in progressive supranuclear palsy.

Nuebling G, Hensler M, Paul S, Zwergal A, Crispin A, Lorenzl S.

J Neurol. 2016 Aug;263(8):1565-74. doi: 10.1007/s00415-016-8169-1. Epub 2016 May 26.

PMID:
27230855
4.

Glioblastoma-dependent differentiation and angiogenic potential of human mesenchymal stem cells in vitro.

Birnbaum T, Hildebrandt J, Nuebling G, Sostak P, Straube A.

J Neurooncol. 2011 Oct;105(1):57-65. doi: 10.1007/s11060-011-0561-1. Epub 2011 Mar 11.

PMID:
21547397

Supplemental Content

Loading ...
Support Center